2025 Preview Infographic: What’s driving pharma growth?

Will the much-awaited biopharma recovery finally arrive in the coming year? This infographic provides key data from our 2025 Preview report, giving you a quick spin through the potential talking points of the year ahead. For the top line forecasts from the report, take a look at our infographic which highlights: Find out: The drugs […]

Share:

Download today








Will the much-awaited biopharma recovery finally arrive in the coming year? This infographic provides key data from our 2025 Preview report, giving you a quick spin through the potential talking points of the year ahead.

For the top line forecasts from the report, take a look at our infographic which highlights:

Find out:

  • The drugs and companies growing pharma’s top line
  • The therapy areas acting as brakes and drivers across the industry
  • The new therapies waiting in the wings

Upcoming Webinar

China Pipelines, Western Portfolios

Tuesday 14th July 3pm BST | 10am ET

Western pharma committed close to $2 billion in licensing deals and acquisitions for China-originated assets in Q1 2026 alone.

Related Content